BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 20628126)

  • 1. Bias and trials stopped early for benefit.
    Goodman S; Berry D; Wittes J
    JAMA; 2010 Jul; 304(2):157; author reply 158-9. PubMed ID: 20628126
    [No Abstract]   [Full Text] [Related]  

  • 2. Bias and trials stopped early for benefit.
    Korn EL; Freidlin B; Mooney M
    JAMA; 2010 Jul; 304(2):157-8; author reply 158-9. PubMed ID: 20628125
    [No Abstract]   [Full Text] [Related]  

  • 3. Bias and trials stopped early for benefit.
    Ellenberg SS; DeMets DL; Fleming TR
    JAMA; 2010 Jul; 304(2):158; author reply 158-9. PubMed ID: 20628127
    [No Abstract]   [Full Text] [Related]  

  • 4. Bias and trials stopped early for benefit.
    Berry SM; Carlin BP; Connor J
    JAMA; 2010 Jul; 304(2):156; author reply 158-9. PubMed ID: 20628124
    [No Abstract]   [Full Text] [Related]  

  • 5. Association between unreported outcomes and effect size estimates in Cochrane meta-analyses.
    Furukawa TA; Watanabe N; Omori IM; Montori VM; Guyatt GH
    JAMA; 2007 Feb; 297(5):468-70. PubMed ID: 17284696
    [No Abstract]   [Full Text] [Related]  

  • 6. Assuring that double-blind is blind.
    Perlis RH; Ostacher M; Fava M; Nierenberg AA; Sachs GS; Rosenbaum JF
    Am J Psychiatry; 2010 Mar; 167(3):250-2. PubMed ID: 20194487
    [No Abstract]   [Full Text] [Related]  

  • 7. Stopping trials for efficacy: an almost unbiased view.
    Goodman SN
    Clin Trials; 2009 Apr; 6(2):133-5. PubMed ID: 19342465
    [No Abstract]   [Full Text] [Related]  

  • 8. Interpreting data from randomized trials: the Scandinavian prostatectomy study illustrates two common errors.
    Vickers A
    Nat Clin Pract Urol; 2005 Sep; 2(9):404-5. PubMed ID: 16474658
    [No Abstract]   [Full Text] [Related]  

  • 9. Statistical principles: myths or facts?
    Sylvester R
    Onkologie; 2003 Dec; 26(6):520-1. PubMed ID: 14709923
    [No Abstract]   [Full Text] [Related]  

  • 10. Statistical trial designs and clinical practice: are they compatible?
    Punt CJ
    Onkologie; 2003 Dec; 26(6):518-9. PubMed ID: 14709922
    [No Abstract]   [Full Text] [Related]  

  • 11. Analysis of clinical data with breached blindness.
    Chow SC; Shao J
    Stat Med; 2004 Apr; 23(8):1185-93. PubMed ID: 15083477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized trials or population-based registries.
    Bergqvist D; Björck M; Säwe J; Troëng T
    Eur J Vasc Endovasc Surg; 2007 Sep; 34(3):253-6. PubMed ID: 17689818
    [No Abstract]   [Full Text] [Related]  

  • 13. Simple efficient bias corrected instrumental variable estimator for randomized trials with noncompliance.
    Chan KC
    Contemp Clin Trials; 2012 Jul; 33(4):786-93. PubMed ID: 22484340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The analysis of binary and categorical data from crossover trials.
    Kenward MG; Jones B
    Stat Methods Med Res; 1994 Dec; 3(4):325-44. PubMed ID: 7889226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Challenges of cluster randomized trials.
    Campbell MJ
    J Comp Eff Res; 2014 May; 3(3):271-81. PubMed ID: 24969154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is it time to use observational data to estimate treatment effectiveness in multiple sclerosis?
    Trojano M
    Neurology; 2007 Oct; 69(15):1478-9. PubMed ID: 17923610
    [No Abstract]   [Full Text] [Related]  

  • 17. Joint testing of mortality and a non-fatal outcome in clinical trials.
    McMahon RP; Harrell FE
    Stat Med; 2001 Apr; 20(8):1165-72. PubMed ID: 11304733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Remarks on the method of propensity score.
    Pearl J
    Stat Med; 2009 Apr; 28(9):1415-6; author reply 1420-3. PubMed ID: 19340847
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical trials methodology: randomization, intent-to-treat, and random-effects regression.
    Atkins DC
    Depress Anxiety; 2009; 26(8):697-700. PubMed ID: 19658122
    [No Abstract]   [Full Text] [Related]  

  • 20. Minimizing bias in randomized trials: the importance of blinding.
    Psaty BM; Prentice RL
    JAMA; 2010 Aug; 304(7):793-4. PubMed ID: 20716744
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.